• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update.

作者信息

Cappellari M, Bovi P

机构信息

Manuel Cappellari, Stroke Unit, Division of Neurology, Department of Neuroscience, Azienda Ospedaliera Univarsitaria Integrata, iazzale A. Stefani 1, 37126 Verona, Italy, Tel.: +39 3397978357, Fax: +30 0458122804, E-mail:

出版信息

Thromb Haemost. 2015 Aug;114(2):440-4. doi: 10.1160/TH14-11-0973. Epub 2015 Mar 26.

DOI:10.1160/TH14-11-0973
PMID:25809649
Abstract
摘要

相似文献

1
Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update.非维生素K拮抗剂口服抗凝剂使用者卒中的静脉溶栓治疗：最新进展
Thromb Haemost. 2015 Aug;114(2):440-4. doi: 10.1160/TH14-11-0973. Epub 2015 Mar 26.
2
[New oral anticoagulants in patients with atrial fibrillation in a urban health center].[城市医疗中心心房颤动患者的新型口服抗凝剂]
Med Clin (Barc). 2016 Mar 18;146(6):280-1. doi: 10.1016/j.medcli.2015.06.016. Epub 2015 Sep 4.
3
Cardiology Patient Pages: Antidotes for Bleeding Caused by Novel Oral Anticoagulants.心脏病学患者专页：新型口服抗凝药所致出血的解毒剂
Circulation. 2016 Jan 12;133(2):e18-9. doi: 10.1161/CIRCULATIONAHA.115.018355.
4
[Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation].[非瓣膜性心房颤动患者中直接口服抗凝剂与维生素K拮抗剂相关因素]
Therapie. 2015 Nov-Dec;70(6):485-92. doi: 10.2515/therapie/2015032. Epub 2015 Jul 29.
5
Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke.急性缺血性卒中溶栓后早期启动利伐沙班或达比加群的安全性
Rev Neurol (Paris). 2015 Sep;171(8-9):613-5. doi: 10.1016/j.neurol.2015.02.012. Epub 2015 Apr 7.
6
[Not Available].[无可用内容]
Lakartidningen. 2018 Dec 4;115:FAS3.
7
Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation.非维生素 K 拮抗剂口服抗凝剂与优化后的醋硝香豆素抗凝“真实世界”在房颤患者中的有效性和安全性比较。
Am J Cardiol. 2018 Sep 1;122(5):785-792. doi: 10.1016/j.amjcard.2018.05.012. Epub 2018 Jun 2.
8
Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.新型口服抗凝药（NOACs）的处方量已超过华法林：探究医生如何选择抗凝治疗药物。
Eur J Clin Pharmacol. 2018 Mar;74(3):323-330. doi: 10.1007/s00228-017-2374-4. Epub 2017 Nov 17.
9
Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?心房颤动中口服抗凝剂的使用欠佳：直接口服抗凝剂的引入是否改善了处方实践？
Am J Cardiovasc Drugs. 2016 Jun;16(3):183-200. doi: 10.1007/s40256-016-0161-8.
10
Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.急性缺血性脑卒中患者的再通治疗：新型口服抗凝剂治疗对出血并发症和结局的影响。
Circulation. 2015 Sep 29;132(13):1261-9. doi: 10.1161/CIRCULATIONAHA.115.015484. Epub 2015 Jul 31.

引用本文的文献

1
A Clinical Observation of Intravenous Thrombolysis in Acute Ischemic Stroke with Minor Trauma.急性缺血性卒中轻微创伤患者静脉溶栓的临床观察
Neuropsychiatr Dis Treat. 2021 Jun 17;17:1983-1987. doi: 10.2147/NDT.S290443. eCollection 2021.
2
Thrombolysis in an acute ischemic stroke patient with rivaroxaban anticoagulation: A case report.利伐沙班抗凝治疗的急性缺血性卒中患者的溶栓治疗：一例报告。
Medicine (Baltimore). 2019 Feb;98(8):e14560. doi: 10.1097/MD.0000000000014560.
3
Dabigatran Plasma Measurement to Guide the Management of Acute Bleeding and Thrombotic Complications.
达比加群血浆检测以指导急性出血和血栓形成并发症的管理。
Eur J Case Rep Intern Med. 2018 Sep 27;5(9):000947. doi: 10.12890/2018_000947. eCollection 2018.
4
Management of patients with stroke treated with direct oral anticoagulants.直接口服抗凝剂治疗的脑卒中患者的管理。
J Neurol. 2018 Dec;265(12):3022-3033. doi: 10.1007/s00415-018-9061-y. Epub 2018 Oct 6.
5
Systemic thrombolysis and endovascular thrombectomy in severe acute ischemic stroke after dabigatran reversal with idarucizumab.在使用依达赛珠单抗逆转达比加群作用后，对严重急性缺血性卒中进行全身溶栓和血管内血栓切除术。
Clin Case Rep. 2018 Feb 27;6(4):698-701. doi: 10.1002/ccr3.1446. eCollection 2018 Apr.
6
A case report of parenchymal hematoma after intravenous thrombolysis in a rivaroxaban-treated patient: Is it a true rivaroxaban hemorrhagic complication?利伐沙班治疗患者静脉溶栓后发生实质内血肿的病例报告：这是真正的利伐沙班出血并发症吗？
Medicine (Baltimore). 2017 Dec;96(51):e9435. doi: 10.1097/MD.0000000000009435.
7
Use of rivaroxaban in patients with stroke.利伐沙班在中风患者中的应用。
Neurol Sci. 2017 May;38(5):745-754. doi: 10.1007/s10072-017-2855-3. Epub 2017 Feb 25.
8
Intravenous thrombolysis for stroke after Dabigatran reversal with Idarucizumab: an update.使用依达赛珠单抗逆转达比加群后进行静脉溶栓治疗卒中：最新进展
J Thromb Thrombolysis. 2017 May;43(4):528-529. doi: 10.1007/s11239-017-1485-1.
9
New Oral Anticoagulants and Their Reversal Agents.新型口服抗凝剂及其逆转剂。
Curr Treat Options Neurol. 2016 Nov;18(11):47. doi: 10.1007/s11940-016-0430-5.
10
Intravenous thrombolysis for acute stroke in a patient on treatment with rivaroxaban.利伐沙班治疗期间急性卒中患者的静脉溶栓治疗
Neurol Sci. 2015 Dec;36(12):2291-2. doi: 10.1007/s10072-015-2336-5. Epub 2015 Jul 26.